Literature DB >> 11673604

GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.

H Wiendl1, C G Bien, P Bernasconi, B Fleckenstein, C E Elger, J Dichgans, R Mantegazza, A Melms.   

Abstract

Eight patients with Rasmussen's encephalitis, 40 patients with noninflammatory focal epilepsy, 104 patients with various neurologic diseases, and 16 healthy donors were tested for the prevalence of antibodies against the GluR3 receptor in serum and CSF. Reactivities against different peptides derived from various portions of this glutamate receptor subtype were detectable in a significantly higher number of patients with focal epilepsy than in those with other neurologic diseases, but they were not specific for the diagnosis of Rasmussen's encephalitis.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11673604     DOI： 10.1212/wnl.57.8.1511

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  29 in total

1.  Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels.

Authors:  Katayun Cohen-Kashi Malina; Yonatan Ganor; Mia Levite; Vivian I Teichberg
Journal:  Neurochem Res       Date:  2006-09-12       Impact factor: 3.996

2.  Blocking immune intrusion into the brain suppresses epilepsy in Rasmussen's encephalitis model.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

3.  Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis.

Authors:  Hania Kebir; Lionel Carmant; François Fontaine; Kathie Béland; Ciprian M Bosoi; Nathalie T Sanon; Jorge I Alvarez; Sébastien Desgent; Camille L Pittet; David Hébert; Marie-Josée Langlois; Rose-Marie Rébillard; Dang K Nguyen; Cécile Cieuta-Walti; Gregory L Holmes; Howard P Goodkin; John R Mytinger; Mary B Connolly; Alexandre Prat; Elie Haddad
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

4.  In Rasmussen encephalitis, hemichannels associated with microglial activation are linked to cortical pyramidal neuron coupling: a possible mechanism for cellular hyperexcitability.

Authors:  Carlos Cepeda; Julia W Chang; Geoffrey C Owens; My N Huynh; Jane Y Chen; Conny Tran; Harry V Vinters; Michael S Levine; Gary W Mathern
Journal:  CNS Neurosci Ther       Date:  2014-12-01       Impact factor: 5.243

Review 5.  Autoimmune encephalitis and its relation to infection.

Authors:  Arun Venkatesan; David R Benavides
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

Review 6.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 7.  [Recent insights into Rasmussen encephalitis].

Authors:  C G Bien; C E Elger
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 8.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

9.  Elevated expression of EBV and TLRs in the brain is associated with Rasmussen's encephalitis.

Authors:  Xin Wang; Yisong Wang; Dong Liu; Peigang Wang; Dongying Fan; Yuguang Guan; Tianfu Li; Guoming Luan; Jing An
Journal:  Virol Sin       Date:  2017-10-30       Impact factor: 4.327

Review 10.  Causes of CNS inflammation and potential targets for anticonvulsants.

Authors:  Mercé Falip; Xavier Salas-Puig; Carlos Cara
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.